WHO ICTRP trial
Exploratory double-blind randomized placebo-controlled trial of Metformin and…
KCT0009342 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0009342 |
|---|---|
| Public title | Exploratory double-blind randomized placebo-controlled trial of Metformin and Ursodeoxycholic acid (UDCA) to treat post-acute sequelae of SARS-CoV-2 infection (PASC) |
| Scientific title | Exploratory double-blind randomized placebo-controlled trial of Metformin and Ursodeoxycholic acid (UDCA) to treat post-acute sequelae of SARS-CoV-2 infection (PASC) |
| Primary sponsor | Asan Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase4 |
| Countries | Korea, Republic of |
| Conditions | Codes for special purposes |
| Interventions | Drug : 1. Drugs for clinical trials 1) Test medication 1: 500 milligrams of Diabex Table (Diabex Tab. 500 mg) - Main ingredients and contents: Metformin hydrochloride (500 mg of Metformin hydrochloride) - Characteristics: White circular… |
| Registration date | Apr 15, 2024 |
| Target size | 396 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: